Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapy

Neoadjuvant chemotherapy assessment is imperative for prognostication and clinical management of locally advanced gastric cancer. We propose an incremental supervised contrastive learning model (iSCLM), an interpretable artificial intelligence framework integrating pretreatment CT scans and H&E-stained biopsy images, for improved decision-making regarding neoadjuvant chemotherapy. We have constructed and tested iSCLM using retrospective data from 2,387 patients across 10 medical centers and evaluated its discriminative ability in a prospective cohort (132 patients; ChiCTR2300068917). iSCLM achieves areas under receiver operating characteristic curves of 0.846-0.876 across different test cohorts. Computed tomography (CT) and pathological attention heatmaps from Shapley additive explanations and global sort pooling illustrate additional benefits for capturing morphological features through supervised contrastive learning. Specifically, pathological top-ranked tiles exhibit decreased distances to tumor-invasive borders and increased inflammatory cell infiltration in responders compared with non-responders. Moreover, CD11c expression is elevated in responders. The developed interpretable model at the molecular pathology level accurately predicts chemotherapy efficacy.

Authors

Institutions

Publication Details

Journal
Cell Reports Medicine
Published
2024-12-01
DOI
https://doi.org/10.1016/j.xcrm.2024.101848
Citations
21
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
8.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapy

Dinggang G. Shen, Z. Wang, Tao Xu, Jingao Xu et al.
21 citations
Cell Reports Medicine
Gastric Cancer Management and Outcomes
8.80
article

Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapy

Dinggang G. Shen, Z. Wang, Tao Xu, Jingao Xu, Qiong Xiao, Yi Ba, Zitong Wang, Peng Gao, Lijie He, Guan Wang, Jing Yi, Ting Deng, Xianchun Gao, Yu Fu, Yingying Feng, Yong Zhang, Erdong Yao, Jiangdian Song, Ya Long, Xue Jiang, Liying Zhang, Yingjie Zhang, Xiaoyan Li, Yan Zhao, Jinghua Sun, Minwen Zheng, Miao Yuan, Hanyu Chen, Hui Juan Jennifer Tan, Yanhong Deng, Junhua Zhao, Yuchong Yang, Jipeng Mei, Zhicheng Wang, Bin Wang
article en
21 citations

Abstract

Neoadjuvant chemotherapy assessment is imperative for prognostication and clinical management of locally advanced gastric cancer. We propose an incremental supervised contrastive learning model (iSCLM), an interpretable artificial intelligence framework integrating pretreatment CT scans and H&E-stained biopsy images, for improved decision-making regarding neoadjuvant chemotherapy. We have constructed and tested iSCLM using retrospective data from 2,387 patients across 10 medical centers and evaluated its discriminative ability in a prospective cohort (132 patients; ChiCTR2300068917). iSCLM achieves areas under receiver operating characteristic curves of 0.846-0.876 across different test cohorts. Computed tomography (CT) and pathological attention heatmaps from Shapley additive explanations and global sort pooling illustrate additional benefits for capturing morphological features through supervised contrastive learning. Specifically, pathological top-ranked tiles exhibit decreased distances to tumor-invasive borders and increased inflammatory cell infiltration in responders compared with non-responders. Moreover, CD11c expression is elevated in responders. The developed interpretable model at the molecular pathology level accurately predicts chemotherapy efficacy.

Cell Reports MedicineVol. 5(12)
Army Medical University (CN), Sun Yat-sen University (CN), Dalian Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), Tianjin Medical University Cancer Institute and Hospital (CN), National Clinical Research Center for Digestive Diseases (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Second Affiliated Hospital of Dalian Medical University (CN), Liaoning Provincial People's Hospital (CN), Shenyang Fifth People Hospital (CN), Southwest Hospital (CN), Neusoft (China) (CN), United Imaging Healthcare (China) (CN), First Hospital of China Medical University (CN), First Affiliated Hospital of Zhengzhou University (CN), Xijing Hospital (CN), Liaoning Cancer Hospital & Institute (CN), China Medical University (CN), Northeastern University (CN), Air Force Medical University (CN)
National Natural Science Foundation of China, China Medical University, Peking Union Medical College Hospital, National Science and Technology Major Project, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 2%
Gastric Cancer Management and Outcomes
8.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.